Table 3B.
PVR < 300 | PVR ≥ 300 | Difference | 95% CI | P‐value | |
---|---|---|---|---|---|
dyn·s·cm−5 | dyn·s·cm−5 | ||||
(<3.75 WU) | (≥3.75 WU) | ||||
(n = 467) | (n = 94) | ||||
30 day all‐cause mortality, n (%) | 30 (6.4%) | 24 (25.5%) | 19.1% | 10.0 to 28.2% | <0.01 |
Transplant failure, n (%) | 19 (4.1%) | 20 (21.2%) | 17.1% | 8.7 to 25.5% | <0.01 |
Acute rejection, n (%) | 1 (0.2%) | 1 (1.1%) | 0.9% | −1.3 to 3.1% | 0.21 |
Infection/sepsis, n (%) | 7 (1.5%) | 2 (2.1%) | 0.6% | −2.5 to 3.7% | 0.66 |
Malignancy, n (%) | 0 (0.0%) | 0 (0.0%) | 0.0% | n.a. | n.a. |
Thromboembolic event/bleeding, n (%) | 3 (0.6%) | 1 (1.1%) | 0.5% | −1.7 to 2.7% | 0.66 |
CI, confidence interval; dyn, g·cm·s−2; n.a., not applicable; PVR, pulmonary vascular resistance; WU, Wood unit (≙ 80 dyn·s·cm−5).